<?xml version="1.0" encoding="UTF-8"?>
<p>The spike protein (S), giving a crown‐like appearance to virion surface, render diverse molecular actions that usually mediates the coronavirus entry into the specific host (Belouzard, Chu, &amp; Whittaker, 
 <xref rid="ddr21709-bib-0011" ref-type="ref">2009</xref>). The spike protein of SARS‐CoV and SARS‐CoV‐2 shares ∼76% amino acid identity; however, SARS‐CoV‐2 S protein binds 10 times more strongly than SARS‐CoV S protein to their common host cell receptor (Du et al., 
 <xref rid="ddr21709-bib-0044" ref-type="ref">2009</xref>; Hoffmann et al., 
 <xref rid="ddr21709-bib-0076" ref-type="ref">2020</xref>; Li, 
 <xref rid="ddr21709-bib-0106" ref-type="ref">2016</xref>; Tortorici et al., 
 <xref rid="ddr21709-bib-0171" ref-type="ref">2019</xref>; Wrapp et al., 
 <xref rid="ddr21709-bib-0187" ref-type="ref">2020</xref>). Heavily glycosylated, the spike protein possesses a large ectodomain, a single‐pass transmembrane anchor, and a short intracellular tail (Li, 
 <xref rid="ddr21709-bib-0106" ref-type="ref">2016</xref>). The ectodomain consists of a receptor‐binding subunit (S1) and a membrane‐fusion subunit (S2; Broer, Boson, Spaan, Cosset, &amp; Corver, 
 <xref rid="ddr21709-bib-0014" ref-type="ref">2006</xref>; Li, 
 <xref rid="ddr21709-bib-0106" ref-type="ref">2016</xref>). During virus entry, the S1 subunit recognizes and interacts to host receptors, and further conformational changes in the S2 subunit assist the fusion between the viral envelope protein and the host cell membrane (Du et al., 
 <xref rid="ddr21709-bib-0044" ref-type="ref">2009</xref>; Li, 
 <xref rid="ddr21709-bib-0106" ref-type="ref">2016</xref>; Tortorici et al., 
 <xref rid="ddr21709-bib-0171" ref-type="ref">2019</xref>). S1 subunit has two major domains: the N‐terminal domain (NTD) and the C‐terminal domain (CTD). Depending on the coronavirus type, either CTD or NTD can function as the RBD and bind with diverse proteins and sugars (Li, 
 <xref rid="ddr21709-bib-0106" ref-type="ref">2016</xref>). Notably, SARS‐CoV and MERS‐CoV utilize CTD to bind their receptors (Kubo, Yamada, &amp; Taguchi, 
 <xref rid="ddr21709-bib-0096" ref-type="ref">1994</xref>; Li et al., 
 <xref rid="ddr21709-bib-0108" ref-type="ref">2005</xref>; Ou et al., 
 <xref rid="ddr21709-bib-0132" ref-type="ref">2020</xref>; N. Wang et al., 
 <xref rid="ddr21709-bib-0181" ref-type="ref">2013</xref>). Then, the proteases found in the cellular environment cause the cleavage of S proteins, which ensures viral fusion. SARS‐CoV‐2 possesses a furin cleavage site between S1 and S2 subunit that permits efficient cleavage by proteases, including furin that determines viral infectivity and host range (Andersen et al., 
 <xref rid="ddr21709-bib-0005" ref-type="ref">2020</xref>; Coutard et al., 
 <xref rid="ddr21709-bib-0032" ref-type="ref">2020</xref>; Ou et al., 
 <xref rid="ddr21709-bib-0132" ref-type="ref">2020</xref>; Walls et al., 
 <xref rid="ddr21709-bib-0177" ref-type="ref">2020</xref>). The S protein of the SARS‐CoV‐2 contains a furin‐like cleavage site, which is absent in other coronaviruses of the same clade (Coutard et al., 
 <xref rid="ddr21709-bib-0032" ref-type="ref">2020</xref>). The S protein also activates the immune response of the host cell toward coronaviruses (Dosch, Mahajan, &amp; Collins, 
 <xref rid="ddr21709-bib-0043" ref-type="ref">2009</xref>; Walls et al., 
 <xref rid="ddr21709-bib-0177" ref-type="ref">2020</xref>). Since the S protein of coronaviruses is reported for their vital associations with initial receptor binding and other critical membrane fusion steps, they could be putative targets for blocking the infection. Prior studies revealed that peptide inhibitors to SARS‐CoV‐2 S protein provide promising avenues for SARS‐CoV‐2 treatment by blocking the S protein interaction with ACE2 and thus efficiently preclude the virus entry into human cells. Moreover, these inhibitors can be used as inhaled therapeutics, preventing the virus activation in the lungs (Ou et al., 
 <xref rid="ddr21709-bib-0132" ref-type="ref">2020</xref>; Walls et al., 
 <xref rid="ddr21709-bib-0177" ref-type="ref">2020</xref>).
</p>
